The EU has eased restrictions on crops developed using novel genetic techniques. While supporters say the technology could ...
The company seems to be doing everything it's supposed to be doing; the stock just isn't responding.
They have at least one thing in common: An exciting pipeline.
Researchers from Skoltech—a VEB.RF group institution—and their colleagues from the U.S. and China have explained how the ...
Scribe awarded more than $25M from CIRM to accelerate additional CRISPR-based gene editing therapies for cardiometabolic ...
Money Talks News on MSN
CRISPR cures cholesterol, FDA demands testing
Scientists used CRISPR technology to disable the cholesterol gene in a groundbreaking study, though widespread availability ...
View CRISPR Therapeutics AG CRSP stock quote prices, financial information, real-time forecasts, and company news from CNN.
CRISPR Therapeutics (NasdaqGM:CRSP) filed a large shelf registration, creating capacity to issue new securities over time.
With the first medical therapy approved and systems like CRISPR-Cas showing up in complex cells, there’s a lot happening in the genome editing field. By Amber Dance/Knowable Magazine Published Jan 26, ...
Banas is associate director of research at the Gene Editing Institute at ChristianaCare, where Kmiec is founder and executive director. The medical promise of CRISPR gene editing can be seen most ...
4don MSN
In vivo CRISPR therapy successfully reduces hereditary angioedema attacks in first Phase III trial
Researchers from Amsterdam UMC, in collaboration with other hospitals, have successfully completed the first Phase III study of an in vivo CRISPR therapy. In this large-scale, double-blind trial, 80 ...
Emerging gene editing platforms are revolutionizing precision medicine, enabling safe and effective genetic modifications for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results